PUNE: The Pune Pharma and Lab Expo, set to take place from May 9th to 11th at the Hindustan Antibiotic Exhibition Ground, Pimpri is gearing up to introduce innovations and technologies in the pharmaceutical and laboratory sectors. This event promises to strengthen business networks both nationally and globally, showcasing over 150 exhibitors from the pharmaceutical, packaging machinery, lab and analytical instruments, and allied industries.
This 3-day exhibition is organized by Exhivision Media, the expo is a premier event in the burgeoning Indian pharma and laboratory equipment market, which is driven by strategic investments in healthcare and advanced R&D infrastructure. The 2024 edition of the Pune Pharma and Lab Expo will provide a dynamic platform for B2B meetings, product displays, and introductions to the latest market innovations aimed at professionals from the pharma, biotech, and healthcare industries.
According to a recent market report, the Laboratory Equipment Services Market is expected to reach $22.1 billion by 2027, growing at a CAGR of 11.1%. This growth is fueled by the increasing need for precise diagnostics, reduced operational downtime, and cost-effective solutions meeting stringent quality standards, with the Asia-Pacific region leading this expansion.
“We are excited to bring the Pune Pharma and Lab Expo back to Pune, which has become a key hub for pharmaceutical innovation and technology,” said Ajeetkumar Shukla, Director of Exhivision Media. “This event not only highlights the latest advancements in our industry but also provides a crucial platform for forging robust business relationships across India and beyond.”
The Expo will feature state-of-the-art exhibits in pharmaceutical machinery, lab and analytical instruments, and a vast array of other products critical to the pharmaceutical and healthcare sectors. The event anticipates over 5,000 visitors, including senior pharma executives, QA/QC managers, R&D professionals, and procurement managers from around the world, offering them unparalleled access to the latest technologies and market trends.
In FY23, the Indian pharma market witnessed a remarkable year-on-year growth of nearly 5%, reaching $49.78 billion. Notably, exports grew modestly by 3%, while the domestic market surged by 7% year-on-year. Developed markets recorded an 8% growth, overcoming challenges posed by the Russia-Ukraine conflict, scarcity of foreign currency in several African countries, and significant depreciation of local currencies in emerging markets.
